Physician profile
Natalie Ouk
NPI 1477031904
$8,025.86
in general payments reported to CMS, 2019-2025
16 companies · $1,444 in 2025
The $1,444 reported for 2025 was more than what 95% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $441 · 2020: $207 · 2021: $1,046 · 2022: $2,701 · 2023: $1,337 · 2024: $850 · 2025: $1,444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,540 · Entertainment: $90.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,540.29 |
| Entertainment | $90.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,503.80 | 2019-2025 | Clareon Panoptix Pro, Rocklatan, Clareon |
| Bausch & Lomb Americas INC. | $1,794.63 | 2022-2025 | Infuse, Vyzulta, Infuse Svs |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,215.26 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $606.65 | 2019-2022 | |
| Amgen INC. | $363.14 | 2024-2025 | Tepezza |
| Glaukos Corporation | $327.93 | 2024-2025 | Photrexa Viscous and Photrexa, Idosetr, Idose |
| Tarsus Pharmaceuticals, INC. | $294.83 | 2024-2025 | Xdemvy |
| Abbvie INC. | $224.87 | 2022-2024 | |
| Biotissue Holdings INC. | $143.32 | 2023 | |
| Allergan, INC. | $138.31 | 2022 | |
| Kedrion Biopharma, INC. | $124.96 | 2025 | Coagadex |
| Coopervision INC. | $107.33 | 2023 | Biofinity Contact Lens |
| Optos, INC. | $104.10 | 2021-2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Ani Pharmaceuticals, INC. | $29.23 | 2025 | Purified Cortrophin Gel |
| Harrow Eye, LLC | $25.20 | 2025 | Vevye |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $22.30 | 2025 | Tearcare System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Ouk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.